Pravastatin
This graph shows the total number of publications written about "Pravastatin" by people in the URMC Research Network by year, and whether "Pravastatin" was a major or minor topic of these publication.
Below are the most recent publications written about "Pravastatin" by people in Profiles.
-
Yao HW, Mao LG, Zhu JP. Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol. 2006 Sep; 33(9):793-7.
-
Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc. 2005 May; 80(5):587-95.
-
Schwartz RG, Pearson TA, Kalaria VG, Mackin ML, Williford DJ, Awasthi A, Shah A, Rains A, Guido JJ. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol. 2003 Aug 20; 42(4):600-10.
-
Houghton JL, Pearson TA, Reed RG, Torosoff MT, Henches NL, Kuhner PA, Philbin EF. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms. Chest. 2000 Sep; 118(3):756-60.
-
Pearson TA. Lipid-lowering therapy in low-risk patients. JAMA. 1998 May 27; 279(20):1659-61.
-
Pearson TA, Marx HJ. The rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications. Am J Cardiol. 1993 Nov 1; 72(14):1072-3.
-
Steingo L, Altona B, Anderson GW, Benkenstein TM, Bennett JM, Bhoola RL, Blake TA, Blomerus P, Botha AP, Branken TI, et al. Early experience with pravastatin in South African patients with type II hyperlipidaemia. S Afr Med J. 1992 Dec; 82(6):488.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
